E
Barinthus Biotherapeutics plc BRNS
$1.20 $0.0151.27% NASDAQ
Recommendation
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
--
EPS (TTM)

06/30/2025 03/31/2025 12/31/2024 09/30/2024 06/30/2024
Revenue -- -- -- -- --
Total Other Revenue -- -- -- -- --
Total Revenue -- -- -- -- --
Cost of Revenue -100.20% -25.90% -88.71% 152.82% -50.83%
Gross Profit 100.20% 25.90% 88.71% 1,853.75% 27.13%
SG&A Expenses 113.64% 103.23% -124.73% 1,045.06% -45.15%
Depreciation & Amortization -- -- -- -- --
Other Operating Expenses 97.75% -480.00% -- -- --
Total Operating Expenses 24.95% 24.69% -86.30% 59.26% -32.62%
Operating Income -24.95% -24.69% 86.30% 39.58% 31.75%
Income Before Tax -24.78% -26.50% -13.68% 44.73% 32.09%
Income Tax Expenses -257.14% 40.54% 100.37% 99.50% 99.38%
Earnings from Continuing Operations -24.69% -26.66% -19.09% 42.39% 28.88%
Earnings from Discontinued Operations -- -- -- -- --
Extraordinary Item & Accounting Change -- -- -- -- --
Minority Interest in Earnings -83.33% -67.74% 1,800.00% -60.53% -45.45%
Net Income -24.77% -26.85% -18.78% 42.34% 28.87%
EBIT -24.95% -24.69% 86.30% 39.58% 31.75%
EBITDA -22.78% -21.86% 89.17% 41.43% 33.04%
EPS Basic -20.73% -22.15% -14.12% 43.65% 30.01%
Normalized Basic EPS -20.89% -22.39% 90.09% 44.33% 33.19%
EPS Diluted -20.73% -22.50% -13.62% 43.24% 30.05%
Normalized Diluted EPS -20.89% -22.39% 90.09% 44.33% 33.19%
Average Basic Shares Outstanding 3.34% 3.85% 4.07% 2.30% 1.65%
Average Diluted Shares Outstanding 3.34% 3.85% 4.07% 2.30% 1.65%
Dividend Per Share -- -- -- -- --
Payout Ratio -- -- -- -- --